Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3416106 | Microbes and Infection | 2007 | 8 Pages |
Abstract
Vaccination against pathogen toxins provides a rational approach to prevent morbidity and mortality, and is widely validated in the context of bacterial infections. A saccharide-conjugate vaccine targeting the malaria glycosylphosphatidylinositol toxin glycan could therefore prevent severe disease. This strategy could also reduce the risk posed by ‘rebound’ infections or immunopathology associated with other interventions.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Louis Schofield,